I1QV34.SA IQVIA Holdings Inc.

Healthcare Diagnostics & Research Sao Paulo Exchange
89.73 BRL
Close of Nov 5, 2026
49.30 328.55
Market cap
BRL 237B
P/E
33.5x
P/B
6.70x
ROE
17.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is I1QV34.SA undervalued?

Graham number

The Graham number of IQVIA Holdings Inc. cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

IQVIA Holdings Inc. fundamental analysis

No fundamental analysis for IQVIA Holdings Inc. yet.

IQVIA Holdings Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About IQVIA Holdings Inc.

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services;…

Full company profile